Business Description
Avanos Medical Inc
NAICS : 339113
SIC : 3842
ISIN : US05350V1061
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | 2.39 | |||||
Interest Coverage | 2.64 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.45 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.1 | |||||
3-Year Book Growth Rate | 0.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 25.69 | |||||
Future 3-5Y Total Revenue Growth Rate | 3.96 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.67 | |||||
9-Day RSI | 21.27 | |||||
14-Day RSI | 25.98 | |||||
6-1 Month Momentum % | -3.78 | |||||
12-1 Month Momentum % | -18.42 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.22 | |||||
Quick Ratio | 1.46 | |||||
Cash Ratio | 0.42 | |||||
Days Inventory | 195.31 | |||||
Days Sales Outstanding | 69.42 | |||||
Days Payable | 65.25 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.2 | |||||
Shareholder Yield % | 11.02 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.51 | |||||
Operating Margin % | 4.92 | |||||
Net Margin % | 2.3 | |||||
FCF Margin % | 5.37 | |||||
ROE % | 1.28 | |||||
ROA % | 0.94 | |||||
ROIC % | 1.92 | |||||
ROC (Joel Greenblatt) % | 11.21 | |||||
ROCE % | 2.64 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 47.15 | |||||
Forward PE Ratio | 9.42 | |||||
PE Ratio without NRI | 13.03 | |||||
Price-to-Owner-Earnings | 23.35 | |||||
PS Ratio | 1.09 | |||||
PB Ratio | 0.6 | |||||
Price-to-Tangible-Book | 3.43 | |||||
Price-to-Free-Cash-Flow | 20.28 | |||||
Price-to-Operating-Cash-Flow | 13.38 | |||||
EV-to-EBIT | 21.96 | |||||
EV-to-EBITDA | 10.06 | |||||
EV-to-Revenue | 1.25 | |||||
EV-to-FCF | 23.22 | |||||
Price-to-Projected-FCF | 0.85 | |||||
Price-to-Median-PS-Value | 0.48 | |||||
Price-to-Graham-Number | 1.41 | |||||
Price-to-Net-Current-Asset-Value | 16.02 | |||||
Earnings Yield (Greenblatt) % | 4.55 | |||||
FCF Yield % | 4.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:AVNS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Avanos Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 681.5 | ||
EPS (TTM) ($) | 0.34 | ||
Beta | 1.2 | ||
Volatility % | 38.81 | ||
14-Day RSI | 25.98 | ||
14-Day ATR ($) | 0.587715 | ||
20-Day SMA ($) | 18.025 | ||
12-1 Month Momentum % | -18.42 | ||
52-Week Range ($) | 15.89 - 25.36 | ||
Shares Outstanding (Mil) | 45.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Avanos Medical Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Avanos Medical Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Avanos Medical Inc Frequently Asked Questions
What is Avanos Medical Inc(AVNS)'s stock price today?
When is next earnings date of Avanos Medical Inc(AVNS)?
Does Avanos Medical Inc(AVNS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |